Figure 2.
PFS and OS of patients treated with bortezomib-based regimens (BBRs) and conventional therapy (CT). A, B) pPCL PFS and sPCL PFS; C, D) pPCL OS and sPCL OS.
PFS: Progression-free survival, OS: overall survival, PCL: plasma cell leukemia.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.